Heron Therapeutics, Inc. Stock Performance
as on September 17, 2025 at 1:29 am IST
Day's Low
Day's High
$1.23$1.27
0.81%
Downside
2.42%
Upside
52 Week's Low
52 Week's High
$1.04$2.6816.13%
Downside
116.13%
Upside
Heron Therapeutics, Inc. share price movements today
- Previous Close
- $1.24
- Open
- $1.27
- Volume
- 1.6M
- Day's Low - High
- $1.23 - $1.27
- 52 Week Low - High
- $1.04 - $2.68
Heron Therapeutics, Inc. Historical Returns
- 1 Month Return
- -6.77 %
- 3 Month Return
- -36.41 %
- 1 Year Return
- -34.74 %
- 3 Year Return
- -73.45 %
- 5 Year Return
- -92.36 %
Heron Therapeutics, Inc. Stock Fundamentals & Key Indicators
Check Heron Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$227.3M
EPS (TTM)
-0.0267
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
-0.18
EBITDA
3.6M
Revenue (TTM)
149.7M
Profit Margin
-0.62%
Return On Equity TTM
0.00%
Heron Therapeutics, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Heron Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $227.3M | -92.36% | NA | -0.62% | |
| BUY | $61.1B | 251.26% | -505.15 | -12.96% | |
| NA | $38.7B | NA | NA | -3.89% | |
| BUY | $101.2B | 47.46% | 28.09 | 31.86% | |
| BUY | $59.6B | 0.6% | 14.1 | 31.37% |
Stock Returns calculator for Heron Therapeutics, Inc. Stock including INR - Dollar returns
The Heron Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Heron Therapeutics, Inc. investment value today
Current value as on today
₹70,131
Returns
Returns from Heron Therapeutics, Inc. Stock
Dollar Returns*
₹4,867 (+4.87%)
Analyst Recommendation on Heron Therapeutics, Inc. Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Heron Therapeutics, Inc.. Average target price of $4.75
Heron Therapeutics, Inc. Share Price Target
Get share price movements and forecasts by analysts on Heron Therapeutics, Inc..
What analysts predicted
73.89%UPSIDE
Target Price
$4.75
Current Price
$1.24
Analyzed by
10 Analysts
Target
$4.75
Heron Therapeutics, Inc. target price $4.75, a slight upside of 73.89% compared to current price of $1.24. According to 10 analysts rating.
Heron Therapeutics, Inc. Stock's Interest Amongst Investors
Search interest for Heron Therapeutics, Inc. Stock has decreased by -12% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Heron Therapeutics, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Heron Therapeutics, Inc. Annual Profit & Loss
All numbers in Millions USD
Heron Therapeutics, Inc. Quarterly Cash Flow
All numbers in Millions USD
Heron Therapeutics, Inc. Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Heron Therapeutics, Inc.
Insights on Heron Therapeutics, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 184.9%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 102.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 3.66M → -2.38M (in $), with an average decrease of 109.2% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 40.78M → 37.2M (in $), with an average decrease of 4.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, HRTX stock has moved down by -36.4%
About Heron Therapeutics, Inc.
| Organisation | Heron Therapeutics, Inc. |
| Headquarters | 100 Regency Forest Drive, Cary, NC, United States, 27518 |
| Industry | Health Technology |
| CEO | Mr. Craig Alexander Collard |
| E-voting on shares | Click here to vote |
Key Management of Heron Therapeutics, Inc.
Name | Title |
|---|---|
Mr. Craig Alexander Collard | CEO & Director |
Ms. Ira Duarte | Executive VP & CFO |
Mr. Ryan Craig | Vice President of Marketing |
Dr. John C. Arthur Ph.D. | Senior Vice President of Manufacturing & Supply |
Mr. Robert Sullivan | Senior Vice President of Oncology Care Franchise & Commercial Operations |
Dr. William P. Forbes Pharm. D., Pharm.D. | Executive VP & Chief Development Officer |
Mr. Mark E. Hensley | Executive VP & COO |
Melissa Jarel | Executive Director of Legal |
Mr. John Aiken | Executive Director of People Management & Training |
Mr. Brett Fleshman | Chief Business Officer |
FAQs
What is Heron Therapeutics, Inc. share price today?
Heron Therapeutics, Inc. share price today is $1.24 as on at the close of the market. Heron Therapeutics, Inc. share today touched a day high of $1.27 and a low of $1.23.
What is the 52 week high and 52 week low for Heron Therapeutics, Inc. share?
Heron Therapeutics, Inc. share touched a 52 week high of $2.68 on and a 52 week low of $1.04 on . Heron Therapeutics, Inc. stock price today i.e. is closed at $1.24,which is 53.73% down from its 52 week high and 19.23% up from its 52 week low.
What is Heron Therapeutics, Inc.'s market capitalisation today?
Heron Therapeutics, Inc. market capitalisation is $0.00T as on .
How to invest in Heron Therapeutics, Inc. Stock (HRTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Heron Therapeutics, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Heron Therapeutics, Inc. Shares that will get you 1.2097 shares as per Heron Therapeutics, Inc. share price of $1.24 per share as on September 17, 2025 at 1:29 am IST.
What is the minimum amount required to buy Heron Therapeutics, Inc. Stock (HRTX) from India?
Indian investors can start investing in Heron Therapeutics, Inc. (HRTX) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Heron Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Heron Therapeutics, Inc. share’s latest price of $1.24 as on September 17, 2025 at 1:29 am IST, you will get 8.0645 shares of Heron Therapeutics, Inc.. Learn more about
fractional shares .
What are the returns that Heron Therapeutics, Inc. has given to Indian investors in the last 5 years?
Heron Therapeutics, Inc. stock has given -92.36% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?